BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Choe AR, Shim KN, Park Y, Song EM, Tae CH, Jung SA. Cost-Effectiveness, Efficacy, and Safety Analysis of Tailored Therapy in Patients with Helicobacter pylori Infection. J Clin Med 2021;10:2619. [PMID: 34198677 DOI: 10.3390/jcm10122619] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Maghami AA, Mobarez AM, Yadegar A, Nikkhah M, Sadeghi A, Esmaeili S. Assessment of Helicobacter pylori positive infected patients according to Clarithromycin resistant 23S rRNA, rpl22 associated mutations and cyp2c19*1, *2, *3 genes pattern in the Early stage of Gastritis. BMC Res Notes 2022;15:335. [PMID: 36284359 DOI: 10.1186/s13104-022-06227-5] [Reference Citation Analysis]
2 Nyssen OP, Espada M, Gisbert JP. Empirical vs. Susceptibility-Guided Treatment of Helicobacter pylori Infection: A Systematic Review and Meta-Analysis. Front Microbiol 2022;13:913436. [DOI: 10.3389/fmicb.2022.913436] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Durazzo M, Ferro A, Fagoonee S, Pellicano R. Trends in the Comprehension and Management of Gastrointestinal Tract Disorders. J Clin Med 2022;11:1730. [PMID: 35330054 DOI: 10.3390/jcm11061730] [Reference Citation Analysis]
4 Wang Y, Gong X, Liu D, Zeng R, Zhou L, Sun X, Liu D, Xie Y. Characteristics of Helicobacter pylori Heteroresistance in Gastric Biopsies and Its Clinical Relevance. Front Cell Infect Microbiol 2022;11:819506. [DOI: 10.3389/fcimb.2021.819506] [Reference Citation Analysis]